ArticleJMIR research protocols2019

Monitoring of Vedolizumab Infusion Therapy (MOVE-IT) Response With Fecal Inflammation Markers, Ultrasound, and Trough Serum Level in Patients With Ulcerative Colitis: Protocol for a Multicentric, Prospective, Noninterventional Study.

Jimmi Cording et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.